文献速递传染病防控与疫情报告免疫规划

高效价口蹄疫O1 Manisa单价疫苗在免疫后7天或4天攻毒牛中的保护效果

Protective effects of high-potency FMDV O1 Manisa monovalent vaccine in cattle challenged with FMDV O/SKR/2010 at 7 or 4 days post vaccination.
PubMed 文献 · Vaccine · 2017-08-05

研究测试高效价O1 Manisa疫苗在免疫后4天或7天对牛抵抗O/SKR/2010口蹄疫病毒攻击的保护能力。结果显示免疫后7天攻毒可保护50%牛免于临床疾病,但免疫后4天攻毒无保护作用;免疫后7天攻毒牛病毒血症显著降低,但鼻和口腔分泌物病毒水平无影响;免疫后7天攻毒牛中和抗体水平与临床保护相关。所有动物均血清转阳,无 sterile 保护,两个疫苗组持续感染动物数相等。

要点

  • 免疫后7天攻毒可保护50%牛免于临床疾病,免疫后4天攻毒无保护作用。
  • 免疫后7天攻毒牛病毒血症较未免疫对照显著降低,免疫后4天攻毒无此效果。
  • 免疫后7天攻毒牛中和抗体水平与临床保护相关,所有动物均血清转阳。

核心结论

  • 高效价O1 Manisa疫苗在攻毒前7天接种可为牛提供部分保护,若发生O/SKR/2010或相关病毒疫情,与其它控制措施联合使用有助于限制口蹄疫病毒传播。

研究设计与样本

  • 研究测试高效价O1 Manisa单价疫苗在牛免疫后4天或7天对O/SKR/2010口蹄疫病毒攻击的保护能力。

主要发现

  • 疫苗在攻毒前7天接种保护50%牛免于临床疾病,但攻毒前4天接种无保护作用。
  • 与未免疫对照相比,免疫后7天攻毒牛病毒血症显著降低,免疫后4天攻毒牛无显著降低。
  • 无论接种时间如何,鼻和口腔分泌物中检测到的病毒水平均无影响。
  • 免疫后7天攻毒牛检测到的中和抗体水平与临床保护相关。
  • 所有动物对口蹄疫病毒非结构蛋白血清转阳,提示无 sterile 保护;两个疫苗组持续感染动物数相等。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Serotype O foot-and-mouth disease (FMD) virus belonging to the SEA topotype continues to be a significant problem in the Eastern Asia region, with outbreaks in Japan and South Korea resulting in the culling of over 3.5 million cattle and pigs in recent years. High-potency O1 Manisa vaccine was previously shown to provide protection in cattle 21days post vaccination (dpv) following challenge with a representative virus, O/SKR/2010. This study tested the ability of the O1 Manisa vaccine to protect cattle from infection and disease with the O/SKR/2010 virus within just 4 or 7days post vaccination. The vaccine protected 50% of cattle from clinical disease when administered 7days prior to challenge, but was not protective with just 4days between vaccination and challenge. Viraemia was significantly reduced in animals challenged 7 dpv but not 4 dpv, compared to unvaccinated controls, however, there were no effects on the level of virus detected in nasal and oral secretions regardless of vaccination time. The level of neutralising antibodies detected in cattle challenged 7 dpv correlated with protection from clinical disease. All animals seroconverted to FMDV non-structural proteins, suggesting no sterile protection. An equal number of animals became persistently infected in both vaccine groups. The results indicated that high-potency O1 Manisa vaccine administered just 7days prior to challenge should provide partial protection of cattle if an outbreak of O/SKR/2010, or related viruses, occurs, and would be useful to limit spread of FMDV when used in conjunction with other control measures.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Horsington J, Perez CB, Maradei E, et al. Protective effects of high-potency FMDV O1 Manisa monovalent vaccine in cattle challenged with FMDV O/SKR/2010 at 7 or 4 days post vaccination. Vaccine. 2017. PMID: 28789849. doi:10.1016/j.vaccine.2017.07.102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。